v2.3.0.15

Segment Reporting

9 Months Ended

Sep. 30, 2011

Segment Reporting [Abstract]

Segment Reporting

12. Segment Reporting. The Company has four reportable segments: Life Sciences, Healthcare, Physician and IT and Engineering. The Company's management evaluates the performance of each segment primarily based on revenues, gross profit and operating income. The information in the following table is derived directly from the segments' internal financial reporting used for corporate management purposes.

The following table presents revenues, gross profit and operating income by reportable segment (in thousands):

		Three Months Ended								Nine Months Ended
		September 30,								September 30,
		2011				2010				2011				2010
Revenues:
Life Sciences		$	41,820			$	30,060			$	114,403			$	78,621
Healthcare			27,091				19,863				68,671				57,739
Physician			23,385				18,789				56,905				56,077
IT and Engineering			70,074				47,429				195,512				124,476
Total Revenues		$	162,370			$	116,141			$	435,491			$	316,913
Gross Profit:
Life Sciences		$	14,163			$	11,194			$	39,025			$	26,603
Healthcare			7,458				6,849				19,242				17,570
Physician			7,794				5,601				18,726				17,870
IT and Engineering			25,113				17,459				69,483				45,179
Total Gross Profit		$	54,528			$	41,103			$	146,476			$	107,222
Operating Income:
Life Sciences		$	3,026			$	2,353			$	7,378			$	3,755
Healthcare			(522	)			(303	)			(3,423	)			(4,138	)
Physician			2,194				953				3,961				3,734
IT and Engineering			9,038				4,439				23,014				8,415
Total Operating Income		$	13,736			$	7,442			$	30,930			$	11,766

The Company operates internationally, with operations mainly in the United States, Europe, Canada, Australia and New Zealand. The following table presents revenues by geographic location (in thousands):

		Three Months Ended								Nine Months Ended
		September 30,								September 30,
		2011				2010				2011				2010
Revenues:
Domestic		$	144,756			$	107,568			$	385,046			$	295,527
Foreign			17,614				8,573				50,445				21,386
Total Revenues		$	162,370			$	116,141			$	435,491			$	316,913

The Company does not report Life Sciences and Healthcare segments' total assets separately as the operations are largely centralized. The following table presents total assets as allocated by reportable segment (in thousands):

		September 30, 2011				December 31, 2010
Total Assets:
Life Sciences and Healthcare		$	107,793			$	74,979
Physician			82,778				63,908
IT and Engineering			216,158				202,229
Total Assets		$	406,729			$	341,116

X

- Details

Name:	asgn_SegmentReportingAbstract
Namespace Prefix:	asgn
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

This element may be used to capture the complete disclosure of reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10% or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 131

+ Details

Name:	us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix:	us-gaap
Data Type:	us-types:textBlockItemType
Balance Type:	na
Period Type:	duration